In consultation with the American College of Obstetricians and Gynecologists and the Society for Maternal Fetal-Medicine, CDC has developed interim guidance for pregnant women returning to the United States from areas with Zika virus transmission. This guidance advises obstetricians and other healthcare professionals who care for pregnant women how to screen, test, and manage pregnant women returning from these areas. Healthcare professionals should ask all pregnant women about recent travel to the areas with ongoing Zika virus transmission.
Pregnant women who report such travel and symptoms of fever, rash, muscle aches, or conjunctivitis (pink eye) during or within 2 weeks of their travel should be tested for Zika virus infection. Positive tests for Zika should be reported to the appropriate local or state health department. Obstetricians and healthcare professionals who care for pregnant women who test positive for Zika virus infection should consider scheduling regular ultrasounds to monitor the growth of the fetus. Because no medication is available to treat Zika virus disease, treatment for pregnant women and the general population focuses on easing symptoms. Pregnant women who have fever should be treated with acetaminophen.
Report: Interim Guidelines for Pregnant Women During a Zika Virus Outbreak – United States, 2016, Emily E. Petersen, MD; J. Erin Staples, MD, PhD; Dana Meaney-Delman,, MD; Marc Fischer, MD; Sascha R. Ellington, MSPH; William M. Callaghan, MD; Denise J. Jamieson, MD, Morbidity and Mortality Weekly Report (MMWR), doi: 10.15585/mmwr.mm6502e1er, published 19 January 2016.